Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Operations

v3.3.1.900
Consolidated Statement of Operations - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Revenues:    
Royalty fees $ 4,515,203 $ 3,194,286
Franchise fees 2,471,259 $ 1,933,500
Revenues and management fees from company clinics 3,651,273
Advertising fund revenue 1,191,124 $ 459,493
IT related income and software fees 808,070 840,825
Regional developer fees 866,802 478,500
Other revenues 331,700 210,058
Total revenues 13,835,431 7,116,662
Cost of revenues:    
Franchise cost of revenues 2,642,451 2,081,382
IT cost of revenues 177,462 264,440
Total cost of revenues 2,819,913 2,345,822
Selling and marketing expenses 3,691,782 1,117,163
Depreciation and amortization 1,268,955 210,123
General and administrative expenses 15,371,223 5,070,263
Total selling, general and administrative expenses 20,331,960 6,397,549
Loss from operations (9,316,442) $ (1,626,709)
Other income (expense):    
Bargain purchase gain 261,147
Other income (expense), net 22,119 $ (64,075)
Total other income (expense) 283,266 (64,075)
Loss before income tax (expense) benefit (9,033,176) (1,690,784)
Income tax (expense) benefit 235,855 (1,340,436)
Net loss and comprehensive loss $ (8,797,321) $ (3,031,220)
Loss per share:    
Basic and diluted loss per share (in dollars per share) $ (0.88) $ (0.56)
Weighted average shares (in shares) 10,042,001 5,451,851